The findings of this investigation provide additional evidence supporting the potential therapeutic application of mangiferin in the management of allergic rhinitis by activating Nrf2/HO‐1 signaling and inhibiting NF‐κB signaling. The gene discussed is NFKB1; the disease is allergic rhinitis.